FDA Drug Recalls

Recalls / Class II

Class IID-0457-2025

Product

Lacosamide Oral Solution, USP, 10 mg/mL, 200 mL, Rx Only, Manufactured by: Apotex Inc., Toronto, Ontario, Canada M9L 1T9, Manufactured for: Apotex Corp., Weston FL 33326, NDC 60505-0405-4

Affected lot / code info
Batch # TZ5589, Exp Date: 01/31/2026

Why it was recalled

Defective Container: This recall is being initiated due to a leaking unit stored horizontally.

Recalling firm

Firm
Apotex Corp.
Notification channel
Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit
Type
Voluntary: Firm initiated
Address
2400 N Commerce Pkwy Ste 400, N/A, Weston, Florida 33326-3253

Distribution

Quantity
20,648 bottles
Distribution pattern
US Nationwide.

Timeline

Recall initiated
2025-05-28
FDA classified
2025-06-03
Posted by FDA
2025-06-11
Status
Ongoing

Source: openFDA Drug Enforcement endpoint. Recall record D-0457-2025. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.

Class II recall: drug · FDA Drug Recalls